Observe Medical Management
Management criteria checks 2/4
Observe Medical's CEO is Jorgen Mann, appointed in Aug 2024, has a tenure of 1.25 years. total yearly compensation is NOK4.13M, comprised of 52.1% salary and 47.9% bonuses, including company stock and options. directly owns 0.26% of the company’s shares, worth NOK219.38K. The average tenure of the management team and the board of directors is 1.7 years and 5.8 years respectively.
Key information
Jorgen Mann
Chief executive officer
NOK 4.1m
Total compensation
| CEO salary percentage | 52.07% |
| CEO tenure | 1.3yrs |
| CEO ownership | 0.3% |
| Management average tenure | 1.7yrs |
| Board average tenure | 5.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2025 | n/a | n/a | -NOK 52m |
| Mar 31 2025 | n/a | n/a | -NOK 56m |
| Dec 31 2024 | NOK 4m | NOK 2m | -NOK 59m |
Compensation vs Market: Jorgen's total compensation ($USD405.59K) is about average for companies of similar size in the Norwegian market ($USD341.52K).
Compensation vs Earnings: Insufficient data to compare Jorgen's compensation with company performance.
CEO
Jorgen Mann
Mr. Jørgen Mann has been Chief Executive Officer of Observe Medical ASA since August 2024 and previously served as its Interim Chief Executive Officer since February 2024 until August 2024. He was Chief Co...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 1.3yrs | NOK 4.13m | 0.26% NOK 219.4k | |
| Chief Financial Officer | 1.7yrs | NOK 1.74m | 0.62% NOK 516.6k | |
| Chief Development Officer | 1.8yrs | NOK 3.06m | no data |
Experienced Management: OBSRV's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board | 6.4yrs | NOK 300.00k | 4.59% NOK 3.8m | |
| Member of Advisory Board | 5.8yrs | no data | no data | |
| Member of Advisory Board | 5.8yrs | no data | no data | |
| Independent Director | 3.4yrs | NOK 255.00k | no data | |
| Independent Director | 3.4yrs | NOK 265.00k | 0.46% NOK 383.5k |
Experienced Board: OBSRV's board of directors are considered experienced (5.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/19 09:29 |
| End of Day Share Price | 2025/11/19 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Observe Medical ASA is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.